UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma

Journal for Immunotherapy of Cancer, 2014-05, Vol.2 (1), p.11-11, Article 11

2014

Volltextzugriff (PDF)

OX40 Agonist Therapy Enhances CD8 Infiltration and Decreases Immune Suppression in the Tumor

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5206-5215

2008

Volltextzugriff (PDF)

Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma

Cancer cell international, 2021-05, Vol.21 (1), p.245-245, Article 245

2021

Volltextzugriff (PDF)

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

Breast cancer research and treatment, 2016-02, Vol.156 (1), p.33-43

2016

Volltextzugriff (PDF)

A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous Disease

Translational oncology, 2018-10, Vol.11 (5), p.1137-1146

2018

Volltextzugriff (PDF)

Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology

Veterinary sciences, 2023-05, Vol.10 (5), p.336

2023

Volltextzugriff (PDF)

Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins

Frontiers in chemistry, 2022-02, Vol.10, p.835229-835229

2022

Volltextzugriff (PDF)

Anti‐OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses

European journal of immunology, 2007-01, Vol.37 (1), p.157-166

2007

Volltextzugriff (PDF)

Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells

Experimental cell research, 2017-09, Vol.358 (2), p.369-376

2017

Volltextzugriff (PDF)

Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right

The Journal of immunology (1950), 2009-10, Vol.183 (8), p.4853-4857

2009

Volltextzugriff (PDF)

Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines

Journal of medical microbiology, 2015-02, Vol.64 (Pt 2), p.164-173

2015

Volltextzugriff (PDF)

The role of OX40-mediated co-stimulation in T-cell activation and survival

Critical reviews in immunology, 2009, Vol.29 (3), p.187-201

2009

Volltextzugriff (PDF)

Fasting reduces the incidence of vincristine‐associated adverse events in dogs

Veterinary & comparative oncology, 2021-03, Vol.19 (1), p.61-68

2021

Volltextzugriff (PDF)

Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging

Cancer Immunology, Immunotherapy, 2014-06, Vol.63 (6), p.615-626

2014

Volltextzugriff (PDF)

Signaling Through OX40 Enhances Antitumor Immunity

Seminars in oncology, 2010-10, Vol.37 (5), p.524-532

2010

Volltextzugriff (PDF)

IL-12 Is Required for Anti-OX40-Mediated CD4 T Cell Survival

The Journal of immunology (1950), 2008-02, Vol.180 (4), p.2140-2148

2008

Volltextzugriff (PDF)

OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age

The Journal of immunology (1950), 2009-02, Vol.182 (3), p.1481-1489

2009

Volltextzugriff (PDF)

Early‐onset age‐related changes in dendritic cell subsets can impair antigen‐specific T helper 1 (Th1) CD4 T cell priming

Journal of leukocyte biology, 2014-08, Vol.96 (2), p.245-254

2014

Volltextzugriff (PDF)

Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines

Journal of medical microbiology, 2015-02, Vol.64 (Pt 2), p.164-173

2015

Volltextzugriff (PDF)

IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway

Journal of Immunology, 2006-07, Vol.177 (1), p.234-245

2006

Volltextzugriff (PDF)

HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I

Cell host & microbe, 2007-04, Vol.1 (2), p.121-133

2007

Volltextzugriff (PDF)

NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade

Journal for immunotherapy of cancer, 2015-05, Vol.3 (1), p.18-18, Article 18

2015

Volltextzugriff (PDF)

OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen‐stimulated T cells leading to an increase in cell survival

European journal of immunology, 2011-04, Vol.41 (4), p.1024-1034

2011

Volltextzugriff (PDF)

The effect of aging on OX40 agonist-mediated cancer immunotherapy

Cancer Immunology, Immunotherapy, 2009-12, Vol.58 (12), p.1941-1947

2009

Volltextzugriff (PDF)

Oncolytic virus therapy for cancer

Oncolytic virotherapy, 2013-01, Vol.2, p.31-46

2013

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(132)
Bücher
(2)

Sprache

Englisch
(133)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma

OX40 Agonist Therapy Enhances CD8 Infiltration and Decreases Immune Suppression in the Tumor

Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous Disease

Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology

Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins

Anti‐OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses

Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells

Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right

Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines

The role of OX40-mediated co-stimulation in T-cell activation and survival

Fasting reduces the incidence of vincristine‐associated adverse events in dogs

Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging

Signaling Through OX40 Enhances Antitumor Immunity

IL-12 Is Required for Anti-OX40-Mediated CD4 T Cell Survival

OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age

Early‐onset age‐related changes in dendritic cell subsets can impair antigen‐specific T helper 1 (Th1) CD4 T cell priming

Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines

IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway

HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I

NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade

OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen‐stimulated T cells leading to an increase in cell survival

The effect of aging on OX40 agonist-mediated cancer immunotherapy

Oncolytic virus therapy for cancer

Suchergebnisse filtern